At a glance
Credera supported a pharmaceutical manufacturer in assessing their content strategy, data processes, and marketing technology to determine opportunities to increase their capabilities within consumer marketing. Through implementation of new content management and analytics tools, the global pharmaceutical company was able to create personalised messaging and analyse its performance to prove effectiveness for scaling to additional brands.
Understanding existing data and processes to drive new customer touchpoints.
A leading pharmaceutical manufacturer, who historically focused on marketing to primary care providers (PCPs), needed to understand and accelerate their consumer marketing processes. They recognised the opportunity to enhance engagement through implementing new technologies to modernise their MarTech and analytics capabilities.
The pharmaceutical manufacturer engaged Credera to assess and create a comprehensive process for one of their brands as a pilot for an enhanced digital strategy. This pilot could then be used to improve consumer marketing at scale across their portfolio of international brands.
Building and measuring effective engagement.Credera assessed the existing content, data, and marketing technology empowering the pilot brand to understand current state. Through this assessment, various digital touchpoints were categorised so the types of engagement could be prioritised based on key drivers.
The Credera team then built new customer journeys—unique to key attributes of the patient—to target increased engagement in the brand’s messaging.
To measure the engagement impact, three MarTech tools were integrated into a common data model to allow for deepened analysis and continuous improvement in the touchpoints created.
A Marketing Analytics Platform (MAP) was developed using AWS S3, AWS Glue, Amazon EMR, Amazon Athena, Amazon Redshift, and Amazon SageMaker to aggregate and make sense of customer data. To measure the engagement impact, the MAP solution integrated three MarTech tools into a common data model to allow for deepened analysis and continuous improvement in the touchpoints created.
Connecting personally through new capabilities.
To effectively reach their customers, the pilot brand has personalised landing pages to engage with their consumers. These pages are enabled through an integration to a content management system (CMS) that populates dynamic content and layouts based on personalised customer attributes.
The marketing strategists have a clear understanding of what processes and data can empower new campaigns and have a roadmap to maximise development of future capabilities that can continue to accelerate their digital experience strategy. These global pharmaceutical marketers can utilise enhanced analytics through newly integrated MarTech tools to measure performance and provide reporting through easily accessible dashboards.